3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
4
Unknown
2
Recruiting
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
21
INDUSTRY
3
NETWORK
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Breast
2
Conditions
Breast Neoplasms
2
Interventions
Cisplatin
15
Paclitaxel
14
Taxes
10
Cyclophosphamide
9
Carboplatin
9
Gemcitabine
7
Platinum
6
1,2-diaminocyclohexaneplatinum II citrate
6
Trastuzumab
5
Radiotherapy
5
Oxaliplatin
5
Doxorubicin
5
Docetaxel
5
Cytarabine
5
Capecitabine
5
Brachytherapy
5
fludarabine
4
Rituximab
4
Radiosurgery
4
Fluorouracil
4
Dexamethasone
4
Watchful Waiting
3
Radiotherapy, Intensity-Modulated
3
Pemetrexed
3
Nimorazole
3
Lenalidomide
3
Imatinib Mesylate
3
Idarubicin
3
Gene Expression Profiling
3
thymoglobulin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
NETWORK
×
pertuzumab
×
Clear all
NCT03412643
2023-03-06
FB-12
NSABP Foundation Inc
Phase 2
Unknown
64 enrolled
NCT01850628
2021-10-05
NSABP Biospecimen Discovery Project
NSABP Foundation Inc
Unknown
50 enrolled